Skip to main content
Back
Watch Compare

MAIA Biotechnology, Inc.

Data quality: 83%
MAIA
NYSE Manufacturing Chemicals
$1.28
▲ $0.08 (6.67%)
Mkt Cap: 71.59 M
Price
$1.18
Mkt Cap
71.59 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -18.84 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-1143.14%
Below sector avg (-54.47%)
ROIC-492.28%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.18
Interest CoverageN/A

Valuation

PE (TTM|NTM|2027)
-3.20 | 0.47 | 0.44
Below sector avg (-1.49)
P/B Ratio1718.08
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -3.2 -1.5
P/B 1718.1 1.6
ROE % -1143.1 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.9
D/E — 0.3

Analyst Price Target

2 analysts
Buy
Current
$1.28
+848.0%
Target
$12.14
$10.27
$12.14
$14.00
Forecast
Forward P/E 0.47
Forward EPS $2.70
Est. Revenue 66.27 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 $2.70
$2.70 – $2.70
 66.27 M 1
FY2026 -$0.69
-$0.69 – -$0.69
 0.0 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.13 -$0.14 -5.2%
Q32025 -$0.19 -$0.27 -42.1%
Q22025 -$0.25 -$0.17 +32.8%
Q12025 -$0.18 -$0.16 +11.1%

ETFs Holding This Stock

BRSIX BRSIX
0.06% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -22.40 M
ROE -1143.14% ROA -196.22%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -18.84 M
ROIC -492.28% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.18
Interest Coverage N/A Asset Turnover N/A
Working Capital 1.76 M Tangible Book Value 41,670
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.20 Forward P/E 0.47
P/B Ratio 1718.08 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1.08 Fwd Earnings Yield 212.77%
FCF Yield -26.32%
Market Cap 71.59 M Enterprise Value 71.59 M
Per Share
EPS (Diluted TTM) -0.70 Revenue / Share N/A
FCF / Share -0.31 OCF / Share -0.31
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 84.14%
SBC-Adj. FCF -21.12 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — 0.0 0.0 0.0
Net Income -22.40 M -23.25 M -19.77 M -15.77 M
EPS (Diluted) -0.70 -1.05 -1.49 -1.75
Gross Profit — — — —
Operating Income -24.27 M -16.96 M -20.18 M -16.18 M
EBITDA — — — —
R&D Expenses 453,745.0 10.01 M 11.11 M 8.93 M
SG&A Expenses — — — —
D&A — — — —
Interest Expense — 57.0 6,863.0 6,967.0
Income Tax 2,000.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 9.70 M 10.16 M 7.57 M 12.02 M
Total Liabilities 7.33 M 6.52 M 7.09 M 3.51 M
Shareholders' Equity 2.38 M 3.63 M 477,511.0 8.51 M
Total Debt — — — —
Cash & Equivalents 0.0 0.0 0.0 0.0
Current Assets 9.70 M 10.15 M 7.56 M 11.81 M
Current Liabilities 5.84 M 3.83 M 4.94 M 3.27 M